Use of the TandemHeart Percutaneous Ventricular Assist Device to Support Patients Undergoing High-Risk Percutaneous

Biswajit Kar1, Matthew Forrester, Courtney Gemmato

  • 1Texas Heart Institute at St. Luke's Espiscopal Hospital, P.O. Box 20345, Houston, TX, 77225—0345, USA. temppub@heart.thi.tmc.edu.

Insights

The TandemHeart percutaneous ventricular assist device (pVAD) offers hemodynamic support during high-risk percutaneous coronary intervention (PCI) for patients ineligible for surgery. This approach shows promise for improving outcomes in complex cardiovascular cases.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Devices

Background:

  • Coronary artery bypass grafting (CABG) is standard for unprotected left main coronary artery disease.
  • Severe comorbidities can make CABG unsuitable, necessitating alternative treatments.
  • Percutaneous coronary intervention (PCI) in such cases presents high risks.

Purpose of the Study:

  • To evaluate the use and efficacy of the TandemHeart percutaneous ventricular assist device (pVAD) for hemodynamic support during high-risk PCI.
  • To assess the safety and feasibility of pVAD implementation in patients with severe comorbidities.

Main Methods:

  • The TandemHeart pVAD was utilized for hemodynamic support in 5 consecutive patients undergoing high-risk PCI.
  • Patients were ineligible for CABG due to severe comorbidities.
  • Device insertion and initiation of circulatory support were performed prior to percutaneous revascularization.

Main Results:

  • Successful pVAD insertion and support initiation without immediate complications in all 5 cases.
  • Percutaneous revascularization was successfully completed with pVAD support (average flow 3 L/minute).
  • Four patients recovered uneventfully after short-term pVAD support; one patient experienced mortality due to heart failure post-procedure.

Conclusions:

  • The pVAD can provide adequate hemodynamic protection during high-risk PCI.
  • This device may improve morbidity and mortality rates for high-risk patients.
  • Further research is warranted to explore the full potential of pVAD in complex PCI scenarios.

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...